grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

May 02, 2017

Southcoast Health Selects Omnicell's Medication Management and Analytics Solutions for Installation Across Multiple Facilities

Download PDF

MOUNTAIN VIEW, Calif., May 2, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Southcoast Health has selected the Company's medication management and analytics solutions for improved inventory control, workflow safety, and efficiency within their health system at Charlton Memorial Hospital, St. Luke's Hospital, Tobey Hospital and two non-hospital centers located in southern Massachusetts. Southcoast Health chose a comprehensive set of Omnicell® solutions to replace its existing automated drug dispensing cabinetry and solutions to optimize its medication procurement, preparation, storage, distribution and administration to its patients. 

Many hospitals struggle with the ability to safely and quickly handle all patient needs. As reimbursement for hospitals is increasingly tied to patient safety and satisfaction, the ability to expeditiously deliver high quality care becomes critical to the livelihood of an institution. Leaders in pharmacy and nursing at Southcoast Health determined that Omnicell solutions would be important in their ability to continue providing this high level of care.  

Medication management solutions to be implemented across Southcoast Health's facilities include the Omnicell XT Automated Dispensing System for the safe storage and dissemination of medications, Anywhere RNRemote Medication Management Software for nurses to perform cabinet functions remotely, and Central Pharmacy Manager for optimizing inventory management and workflow. Southcoast Health has also chosen the Performance Center, which combines enterprise software solutions with ongoing expert services to proactively monitor pharmacy operations and deliver actionable insights for improved operational efficiency, regulatory compliance, and patient outcomes. To aid in on-site sterile compounding, Southcoast Health purchased i.v.SOFT® Assist, which provides in-process checks during the IV preparation process and creates an audit trail for reliable dose verification.

Southcoast Health's decision process included several on-site demonstrations as well as visits to facilities that had already implemented Omnicell technology. Pharmacy and nursing personnel also saw immense value in Omnicell's interoperability with the Epic electronic health record (EHR), and Southcoast Health will be adding this interoperability to increase workflow efficiency.

"At Southcoast Health, we strive to provide the best patient care in the most efficient way possible. Drug therapy is a critical part of any healthcare system. A key component of this is properly managing medication availability throughout our facilities," said Jack Evans, executive director, Pharmacy Services at Southcoast Health. "Our decision to adopt Omnicell technology began as a means of upgrading how we handle our medications—but we're converting to a system that provides data analytics, hardware and support that improves our operational pharmacy infrastructure."  

"The interoperability between our EHR and Omnicell solutions promotes order accuracy and provides confidence to our nurses that the right medications will be available when needed," said Tonya Johnson, associate chief nursing officer for Southcoast Health'sSt. Luke's Hospital. "This helps save them substantial time on medication administration processes and increases the time they have to spend directly with their patients."

"It's exciting to see a health system commit to the safety and satisfaction of their patients with such a comprehensive set of our solutions," said J. Christopher Drew, president, North American Automation and Analytics at Omnicell. "Each of these systems substantively aids Southcoast Health in continuing to provide safe and efficient processes for patients and caregivers, and we look forward to helping them achieve their goals."

About Southcoast Health

Southcoast Health is a community-based, health delivery system with multiple access points, offering an integrated continuum of health services throughout Southeastern Massachusetts and Rhode Island. It includes the three acute-care hospitals that make up Southcoast Hospitals GroupCharlton Memorial Hospital in Fall River, St. Luke's Hospital in New Bedford and Tobey Hospital in Wareham; and Southcoast Behavioral Health in Dartmouth, a joint venture hospital with Acadia Healthcare, an international leader in psychiatric and addiction care. Southcoast Health provides advanced clinical services, such as open heart surgery, angioplasty and heart rhythm services, comprehensive cancer care, weight loss surgery, surgery, advanced, and maternity services. For more information, visit

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.

Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.

For more information about Omnicell, Inc. please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.


To view the original version on PR Newswire, visit:

SOURCE Omnicell, Inc.

News Provided by Acquire Media